Core Scientific, Inc. reported $440M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $440M (to Q2 2026). Net Income: −$1.43B, trailing twelve months to Q2 2026. Free Cash Flow: −$958M, trailing twelve months to Q2 2026. Op Margin: −133%, trailing twelve months to Q2 2026.

CORZCore Scientific, Inc.

TechnologyUSD

$17.42

$13.5552 weeks$29.16

CORZ as reported

Core Scientific, Inc. reported $440M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed.

$440M

Revenue, trailing twelve months · to Q2 2026 · +26% against the twelve months before

Net Income: −$1.43B
Net Income · +29% year on year · trailing twelve months to Q2 2026
Free Cash Flow: −$958M
Free Cash Flow · +273% year on year · trailing twelve months to Q2 2026
Op Margin: −133%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for CORZ, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$440M	+26%	Q2 2026
Net Income	−$1.43B	+29%	Q2 2026
EPS	−$4.23	+541%	Q2 2026
Gross Margin	25%	n/a	Q2 2026
Op Margin	−133%	n/a	Q2 2026
Net Margin	−228%	n/a	Q2 2026
ROE	61%	n/a	Q2 2026
ROA	−29%	n/a	Q2 2026
ROIC	8.5%	n/a	Q1 2025 · 5 quarters behind
Free Cash Flow	−$958M	+273%	Q2 2026